Terms: = Bone cancer AND HOXA9, HOX1, 3205, ENSG00000078399, HOX1G, P31269 AND Prognosis
4 results:
1. Prediction of competing endogenous RNA coexpression network as prognostic markers in AML.
Wang JD; Zhou HS; Tu XX; He Y; Liu QF; Liu Q; Long ZJ
Aging (Albany NY); 2019 May; 11(10):3333-3347. PubMed ID: 31164492
[TBL] [Abstract] [Full Text] [Related]
2. Cooperation between AlphavBeta3 integrin and the fibroblast growth factor receptor enhances proliferation of Hox-overexpressing acute myeloid leukemia cells.
Shah CA; Bei L; Wang H; Altman JK; Platanias LC; Eklund EA
Oncotarget; 2016 Aug; 7(34):54782-54794. PubMed ID: 27340869
[TBL] [Abstract] [Full Text] [Related]
3. NUP98 dysregulation in myeloid leukemogenesis.
Moore MA; Chung KY; Plasilova M; Schuringa JJ; Shieh JH; Zhou P; Morrone G
Ann N Y Acad Sci; 2007 Jun; 1106():114-42. PubMed ID: 17442773
[TBL] [Abstract] [Full Text] [Related]
4. CD34+ cell selection is required to assess hoxa9 expression levels in patients with myelodysplastic syndrome.
Heinrichs S; Berman JN; Ortiz TM; Kornblau SM; Neuberg DS; Estey EH; Look AT
Br J Haematol; 2005 Jul; 130(1):83-6. PubMed ID: 15982348
[TBL] [Abstract] [Full Text] [Related]
